Impact of European Medicines Agency (EMA) Clinical Trial Transparency Policies on Health Technology Assessment (HTA) Decisions In the UK
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.793
https://www.valueinhealthjournal.com/article/S1098-3015(18)31093-3/fulltext
Section Title :
Section Order :
108
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31093-3&doi=10.1016/j.jval.2018.04.793